UMN Pharma Inc. announced consolidated earnings results for the first quarter ended March 31, 2016. For the period, the company reported net sales of JPY 35 million compared with JPY 42 million for the same period a year ago. Operating loss was JPY 350 million compared with JPY 485 million for the same period a year ago.

Ordinary loss was JPY 362 million compared with JPY 461 million for the same period a year ago. Net loss attributable to owners of the company was JPY 111 million or JPY 11.65 per basic share compared with JPY 457 million or JPY 47.86 per basic share for the same period a year ago. Loss before income taxes and minority interests was JPY 362,979 million compared with JPY 461,436 million for the same period a year ago.